New webinars available on BOPA website

There are a series of new Webinars available on the BOPA website which were recorded at the recent London Pharmacy Oncology Education Evening.

The BOPA Bursary team gave an update from ASCO18 including some specific trials and their experiences of the scheme.

You can watch a webinar of the whole meeting or just the bits you are interested in:
KEYNOTE-042
TAILORx
PRODIGE-24
PERSEPHONE
Other ASCO scientific highlights
Experience of using social media to disseminate education digitally

The webinars can all be found here: http://bit.ly/BOPAwebinars

Don’t forget that we also broadcast the event live on Periscope and you can watch the replays here: http://bit.ly/BOPAPeriscope
Plus all the Twitter coverage can be found here: https://twitter.com/i/moments/1044195877890478081

We hope this provides some useful inspiration for revalidation CPD entries as we near the 31st October deadline!

Marcus (on behalf of the BOPA Bursary Scheme team)
[email protected]
@eRxPharmacist

Latest News

By Farah Al-sheikhli on 16th April 2026

LCC 2026 Funding Opportunity: Pharmacist Reviewers for ‘Let’s Communicate Cancer’ Programme

Let’s Communicate Cancer review 2026 The BOPA Education and Training Subcommittee have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.…

Read article
By Farah Al-sheikhli on 16th April 2026

NIHR INSIGHT Opening the Doors: Reimagining Inclusion in Health Research

📅 Friday 5 June 2026  🕐 12:00–16:00  📍 1 Frith Street, London W1D 3HZ ✅ Register here About this event NIHR INSIGHT South London welcomes you to join us for an afternoon dedicated…

Read article
By Joseph Williams on 15th April 2026

Thank you – and the launch of the Royal College of Pharmacy (RCPharm)

Thank you for placing your trust in me by voting me onto the English Pharmacy Advisory Council of the Royal College of Pharmacy. I am genuinely grateful for your support…

Read article
By SHBN on 8th April 2026

SHBN Webinar – Safer Handling of Hazardous Medicinal Products: Evidence, Practice and Policy Change

This session will bring together research and policy perspectives to explore the current evidence base, the practical realities faced by healthcare professionals, and the policy considerations shaping future improvements in…

Read article